EcoDrugPlus

Cyclin Dependent Kinase 1

Ensembl ID : ENSPVAG00000015063
Gene Symbol: CDK1
1 Cross references
235 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSPVAG00000007555
Gene Symbol: CDK2
1 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSPVAG00000012131
Gene Symbol: CDK4
1 Cross references
212 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPVAG00000007092
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSPVAG00000003903
Gene Symbol: CDK6
1 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPVAG00000010844
Gene Symbol: CDK7
1 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPVAG00000000960
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSPVAG00000013856
Gene Symbol: CDA
1 Cross references
224 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSPVAG00000011303
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSPVAG00000006874
Gene Symbol: CYP19A1
1 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSPVAG00000013375
Gene Symbol: CYP26A1
1 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSPVAG00000007437
Gene Symbol: CYP46A1
1 Cross references
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).